Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

WHO mourns Lee: World Health Organization Director-General Lee Jong-wook, MD, passed away May 22 following emergency surgery for a blood clot in his brain. Lee, a Korean national, became director-general of the organization in 2003 after dedicating more than 20 years working for WHO. Anders Nordström, PhD, of Sweden, has taken over the post following Lee's sudden death...

You may also be interested in...



People In Brief

Siemens names diagnostics execs: Siemens Medical Solutions appoints Anthony Bihl CEO of its new diagnostics unit following completion of its $5.3 billion acquisition of Bayer's diagnostics business on Jan. 1. Bihl, former president of Bayer Diagnostics, will be assisted by Chief Operating Officer Sid Aroesty, former president and COO of Diagnostic Products Corp., and Chief Financial Officer Jochen Schmitz, who comes to the newly formed subsidiary, called Siemens Medical Solutions Diagnostics, from his CFO post at Siemens' molecular imaging division. Siemens entered the in vitro diagnostics market via a $1.86 billion purchase of Diagnostic Products Corp. last June (1"The Gray Sheet" June 12, 2006, p. 13).... New CEO at Siemens Hearing Instruments: Firm's hearing-aid subsidiary welcomes Christi Pedra as CEO on Jan. 4. The 21-year Siemens veteran, who moves from her position as COO at the Siemens One marketing organization, plans to strengthen customer support and expand the hearing instruments sales force. Pedra replaces William Lankenau, who retired Dec. 31 after 16 years with the company...

People In Brief

Siemens names diagnostics execs: Siemens Medical Solutions appoints Anthony Bihl CEO of its new diagnostics unit following completion of its $5.3 billion acquisition of Bayer's diagnostics business on Jan. 1. Bihl, former president of Bayer Diagnostics, will be assisted by Chief Operating Officer Sid Aroesty, former president and COO of Diagnostic Products Corp., and Chief Financial Officer Jochen Schmitz, who comes to the newly formed subsidiary, called Siemens Medical Solutions Diagnostics, from his CFO post at Siemens' molecular imaging division. Siemens entered the in vitro diagnostics market via a $1.86 billion purchase of Diagnostic Products Corp. last June (1"The Gray Sheet" June 12, 2006, p. 13).... New CEO at Siemens Hearing Instruments: Firm's hearing-aid subsidiary welcomes Christi Pedra as CEO on Jan. 4. The 21-year Siemens veteran, who moves from her position as COO at the Siemens One marketing organization, plans to strengthen customer support and expand the hearing instruments sales force. Pedra replaces William Lankenau, who retired Dec. 31 after 16 years with the company...

Biophan, FDA To Research MRI-Device Compatibility

A research partnership between Biophan Technologies and FDA aims to make it safer for patients with implanted medical devices to undergo magnetic resonance imaging (MRI) procedures

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel